Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cordlife Group Limited (SG:P8A)
SGX:P8A
Holding SG:P8A?
Track your performance easily
P8A Stock Chart & Stats
Day’s RangeS$0 - S$0
52-Week RangeS$0.12 - S$0.48
Previous CloseS$0.14
Volume9.70K
Average Volume (3M)794.98K
Market Cap
S$34.72M
Enterprise Value-S$27.97M
Total Cash (Recent Filing)S$65.17M
Total Debt (Recent Filing)S$2.22M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Nov 14, 2024EPS EstimateN/A
Last Dividend Ex-Date
May 06, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume42,460
30 Day Avg. Volume794,983
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1.24
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cordlife Group News
PremiumCompany Announcements
Cordlife Group Faces Continued Operational Uncertainty
PremiumCompany Announcements
Cordlife Group Adjusts Funds Amid Regulatory Hurdles
PremiumCompany Announcements
Cordlife Group Legal Claim Withdrawn; Caution Advised
PremiumCompany Announcements
Cordlife Group Strives for AABB Re-accreditation
PremiumCompany Announcements
Cordlife Group Foresees Major Profit DropPremiumCompany Announcements
Cordlife Group Updates on Board Member’s Arrest
PremiumCompany Announcements
Cordlife Group Navigates Operational Suspension
PremiumCompany Announcements
Cordlife Group Advises Caution Amid InvestigationOptions Prices
Currently, No data available
---
Ownership Overview
2.01%
Insiders
0.00% Mutual Funds
0.06% Other Institutional Investors
97.93% Public Companies and
Individual Investors
P8A FAQ
What was Cordlife Group Limited’s price range in the past 12 months?
Cordlife Group Limited lowest share price was S$0.12 and its highest was S$0.47 in the past 12 months.
What is Cordlife Group Limited’s market cap?
Currently, no data Available
When is Cordlife Group Limited’s upcoming earnings report date?
Cordlife Group Limited’s upcoming earnings report date is Nov 14, 2024 which is in 76 days.
How were Cordlife Group Limited’s earnings last quarter?
Cordlife Group Limited released its earnings results on Aug 14, 2024. The company reported -S$0.048 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.048.
Is Cordlife Group Limited overvalued?
According to Wall Street analysts Cordlife Group Limited’s price is currently Overvalued.
Does Cordlife Group Limited pay dividends?
Cordlife Group Limited pays a Notavailable dividend of <S$0.01 which represents an annual dividend yield of N/A. See more information on Cordlife Group Limited dividends here
What is Cordlife Group Limited’s EPS estimate?
Cordlife Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cordlife Group Limited have?
Cordlife Group Limited has 267,525,360 shares outstanding.
What happened to Cordlife Group Limited’s price movement after its last earnings report?
Cordlife Group Limited reported an EPS of -S$0.048 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cordlife Group Limited?
Currently, no hedge funds are holding shares in SG:P8A
---
Cordlife Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.55%
12-Months-Change
Fundamentals
Return on Equity
-8.46%
Trailing 12-Months
Asset Growth
-4.29%
Trailing 12-Months
Company Description
Cordlife Group Limited
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood banking services. It operates through the Banking and Diagnostics segments. The Banking segment comprises of cord blood, and cord lining and tissue services, which collects, processes and stores in laboratories. The Diagnostics segment consists of Metascreen, which is anon-invasive metabolic screening test designed for newborn babies, non-invasive prenatal testing and eyescreen, and a paediatric vision-screening services. The company was founded on May 2, 2001 and is headquartered in Singapore.
---
Technical Analysis
---